Relapse of Graves' disease after successful outcome of antithyroid drug therapy: Results of a prospective randomized study on the use of levothyroxine

Thyroid

Volumn 12, Issue 12, 2002, Pages 1119-1128

  Hoermann, Rudolf ^a   Quadbeck, Beate ^b   Roggenbuck, Ulla ^b   Szabolcs, István ^c   Pfeilschifter, Johannes ^d   Meng, Wieland ^e   Reschke, Kirsten ^f   Mann, K ^j   Dettmann, Juergen ^h   Prehn, Brigitte ^b,i   Hirche, Herbert ^b   Mann, Klaus ^b   Clanget, C ^j   Hinke, V ^j   Schatz, H ^j   Takats K ^j   Radacsi A ^j   Foeldes, I ^j   Oo M ^j   Agoston A ^j   Feldkamp, J ^j   Fritzen, R ^j   Santen, R ^j   Schott, M ^j   Scherbaum, W A ^j   Tharandt, L ^j   Cissewski, K ^j   Patkay J ^k   Trilling, T ^j   Vogel, A ^j   Schumm Draeger, P M ^j   Jungheim, K ^j   Freitag, D ^j   Usadel, K H ^j   Akinci, A ^j   Hammes, H P ^j   Helfrich, C ^j   Bretzel, R G ^j   Altenfoerde, G ^j   van Ophemert, S ^j   Becker, W ^j   Huefner, M ^j   Buchinger, W ^j   Langsteger, W ^j   Eber, O ^j   Schindler, A ^l   Spieker, K ^l   Pocsay, G ^j   Seibel, M J ^j   Ziegler, R ^j   Gerhardt, A ^j   Kompa, D ^j   Stamm, B ^j   Zeitz, M ^j   Kapp Helmich, B ^j   Graf, D ^j   Lehnert, H ^j   Weber, M ^j   Engelhardt, D ^j   Greil, W ^j   Kesmarki N ^m   Meszaros J ^j   Heinen, E ^j   Zietz, B ^j   Palitzsch, K D ^j   Hampel, R ^j   Bencsik, Z ⁿ   Vadasz J ^o   Loecsey, Z ^j   Rendl, J ^j   Reiners, C ^j   more..

^a Klinikum Luedenscheid   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e UNIVERSITY OF GREIFSWALD   (Germany)

^f OTTO VON GUERICKE UNIVERSITY   (Germany)

^g Ev Hospital   (Germany)

^h Nuclear Medicine Practice   (Germany)

ⁱ UNIVERSITY OF ROSTOCK   (Germany)

^j NONE   (Germany)

^k NONE   (Germany)

^l NONE   (Germany)

^m NONE   (Hungary)

ⁿ NONE   (Hungary)

^o Department of Oncology Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet   (Hungary)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; L THYROXIN HENNING; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; THIONAMIDE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GOITER; GRAVES DISEASE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RISK FACTOR; THYROID SCINTISCANNING; THYROID WEIGHT;

EID: 0036959615     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072502321085225     Document Type: Article

References (23)

1. Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y, Izumi M 1991 Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1:129-135.
2. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Arai M, Nagasawa T 1991 Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med 324:947-953.
3. Hashizume K, Ichikawa K, Nishii Y, Kobayoshi M, Sakurai A, Miyamoto T, Suzuki S, Takeda T 1992 Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease. J Clin Endocrinol Metab 75:6-10.
4. Ladenson PW 1991 Treatments for Graves' disease - letting the thyroid rest. N Engl J Med 324:989-990.
5. Hershman JM 1995 Editorial: Does thyroxine therapy prevent recurrence of Graves' hyperthyroidism? J Clin Endocrinol Metab 80:1479-1480.
6. Tamai H, Hayaki I, Kawai K, Komaki G, Matsubayashi S, Kuma K, Kumagai LF and Nagataki S 1995 Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. J Clin Endocrinol Metab 80:1481-1484.
7. McIver B, Rae P, Beckett G, Wilkinson E, Gold A, Toft A 1996 Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. N Engl J Med 334:220-224.
8. Pfeilschifter J, Ziegler R 1997 Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: Effects on recurrence of hyperthyroidism and thyroid volume. Europ J Endocrinol 136:81-86.
9. Pujol P, Osman A, Grabar S, Daures JP, Galtier-Dereure F, Boegner C, Baldet L, Raye R, Bringer J, Jaffiol C 1998 TSH suppression combined with carbimazole for Graves' disease: effect on remission and relapse rates. Clin Endocrinol (Oxf) 48:635-640.
10. Rittmaster RS, Abbott EC, Douglas R, Givner ML, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE 1998 Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease. J Clin Endocrinol Metab 83:814-818.
11. Raber W, Kmen E, Waldhausl W, Vierhapper H 2000 Medical therapy of Graves' disease: Effect on remission rates of methimazole alone and in combination with triiodothyronine. Eur J Endocrinol 142-117-124.
12. Glinoer D, de Nayer P, Bex M 2001 Effects of 1-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: A double-blind prospective randomized study. Eur J Endocrinol 144:475-483
13. Hampel R, Kuehlberg T, Klein K, Jerichow JU, Pichmann EG, Clausen V, Schmidt I 1995 Strumapraevalenz in Deutschland groesser als bisher angenommen. Med Klinik 90:342-349.
14. Pocock SJ, Simon R 1975 Sequential treatment assignment with balancing for prognostic factors in the controlled trial. Biometrics 31:103-115.
15. Saller B, Broda N, Heydarian R, Gorges R, Mann K 1998 Utility of third generation thyrotropin assays in thyroid function testing. Exp Clin Endocrinol Diabetes 106 Suppl 4):S29-33.
16. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, Poertl S, Weglöhner W, Hollidt JM, Quadbeck B, Dumont JE, Schumm-Draeger PM, Bergmann A, Mann K, Vassart G, Usadel KH 1999 Second generation assay for TSH-receptor antibodies has superior diagnostic sensitivity in Graves' disease. J Clin Endocrinol Metab 84:90-97.
17. Rendl J, Seybold S, Börner W 1994 Urinary iodide determined by paired-ion reversed-phase HPLC with electrochemical detection. Clin Chem 40:908-913.
18. Reinwein D, Benker G, Lazarus JH, Alexander WD, and the European Multicenter Study Group on antithyroid drug treatment 1993 A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. J Clin Endocrinol Metab 76:1516-1521.
19. Schleusener H, Schwander J, Fischer C, Holle R, Holl G, Badenhoop K, Hensen J, Finke R, Bogner U, Mayr WR, Schernthaner G, Schatz H, Pickardt CR, Kotulla P 1989 Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 120:689-701.
20. Feldt-Rasmussen U, Schleusener H, Carayon P 1994 Metaanalysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab 78:98-102.
21. Vitti P, Rago T, Chiovato L, Pallini S, Santini F, Fiore E, Rocchi R, Martino E, Pinchera A 1997 Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 7:369-375.
22. Kalbfleisch JD, Prentice RL 1980 The Statistical Analysis of Failure Time Data. Wiley, New York.
23. Cox DR, Oakes D 1984 Analysis of Survival Data. Chapman & Hall, London.